Analyst Ratings for Medifast (MED)
MED Rating Summary
MED Price Target Summary
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.00 (-17.5%)
Avg. $ Target:
$23.00 (-17.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/27/2012 | Sidoti | Upgrade | Buy (Neutral) |
N/A (N/A) |
22.37 | 27.88 | 24.63% | Details |
| 7/27/2012 | Northland Securities | Upgrade | Outperform (Market Perform) |
29.00 (16.00) |
22.37 | 27.88 | 24.63% | Details |
| 7/9/2012 | Standpoint Research | Downgrade | Hold (Buy) |
24.00 (N/A) |
20.32 | 27.88 | 37.2% | Details |
| 11/7/2011 | Canaccord Genuity » Updated 6/15/2012 |
Downgrade | Hold (N/A) |
19.00 (N/A) |
15.01 | 27.88 | 85.74% | Details |
| 11/4/2011 | Janney Montgomery Scott | Downgrade | Neutral (N/A) |
17.00 (N/A) |
15.49 | 27.88 | 79.99% | Details |
| 9/28/2011 | Auriga » Updated 5/9/2012 |
New Coverage | Buy (N/A) |
21.00 (N/A) |
16.81 | 27.88 | 65.85% | Details |
| 9/8/2011 | Avondale Partners | New Coverage | Market Outperform (N/A) |
28.00 (N/A) |
15.87 | 27.88 | 75.68% | Details |
| 4/26/2011 | Capstone Investments | New Coverage | Buy (N/A) |
N/A (N/A) |
18.26 | 27.88 | 52.68% | Details |
| 12/1/2010 | Wedbush » Updated 3/14/2012 |
New Coverage | Outperform (N/A) |
23.00 (N/A) |
24.36 | 27.88 | 14.45% | Details |
